Tübingen, Germany

Inge Bayer, Legal Representative


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inge Bayer - Innovator in Oligonucleotide Therapeutics

Introduction

Inge Bayer is a notable legal representative and inventor based in Tübingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting pancreatic tumors. His work exemplifies the intersection of legal expertise and scientific innovation.

Latest Patents

Inge Bayer holds a patent for "Oligonucleotides, agents containing these oligonucleotides, and the use thereof." This invention focuses on specific oligonucleotides that have the potential to inhibit the proliferation of pancreatic tumors. The therapeutic applications of these oligonucleotides suggest a promising avenue for antisense therapy in treating this aggressive form of cancer. He has 1 patent to his name, highlighting his innovative contributions to medical science.

Career Highlights

Bayer is associated with Universitätsklinikum Schleswig-Holstein, where he collaborates with a team of professionals dedicated to advancing medical research and treatment options. His role as a legal representative allows him to navigate the complexities of patent law while supporting groundbreaking research initiatives.

Collaborations

Inge Bayer works alongside esteemed colleagues such as Ernst Bayer and Thomas Ketterer. Their combined expertise fosters a collaborative environment that enhances the development of innovative therapeutic solutions.

Conclusion

Inge Bayer's work in the field of oligonucleotide therapeutics represents a significant advancement in cancer treatment. His innovative approach and legal acumen contribute to the ongoing fight against pancreatic tumors, showcasing the vital role of inventors in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…